TCS vs. JWEL, ACI, REAL, ASO, BABY, GPS, FL, GCT, KAR, and M
Should you be buying Tecsys stock or one of its competitors? The main competitors of Tecsys include Jamieson Wellness (JWEL), TriSummit Utilities Inc. (ACI.TO) (ACI), Real Matters (REAL), Avesoro Resources (ASO), Else Nutrition (BABY), BSM Technologies (GPS), Frontier Lithium (FL), GVIC Communications (GCT), Karmin Exploration (KAR), and Mosaic Capital (M). These companies are all part of the "retail" industry.
Tecsys vs.
Tecsys (TSE:TCS) and Jamieson Wellness (TSE:JWEL) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, community ranking, risk, analyst recommendations, valuation, earnings and institutional ownership.
In the previous week, Tecsys' average media sentiment score of 0.00 equaled Jamieson Wellness'average media sentiment score.
Tecsys presently has a consensus target price of C$46.50, suggesting a potential upside of 1.57%. Jamieson Wellness has a consensus target price of C$37.81, suggesting a potential upside of 7.16%. Given Jamieson Wellness' higher probable upside, analysts plainly believe Jamieson Wellness is more favorable than Tecsys.
Jamieson Wellness received 22 more outperform votes than Tecsys when rated by MarketBeat users. However, 70.63% of users gave Tecsys an outperform vote while only 63.27% of users gave Jamieson Wellness an outperform vote.
Jamieson Wellness has higher revenue and earnings than Tecsys. Jamieson Wellness is trading at a lower price-to-earnings ratio than Tecsys, indicating that it is currently the more affordable of the two stocks.
35.5% of Tecsys shares are owned by institutional investors. Comparatively, 55.6% of Jamieson Wellness shares are owned by institutional investors. 17.1% of Tecsys shares are owned by company insiders. Comparatively, 0.3% of Jamieson Wellness shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Tecsys pays an annual dividend of C$0.32 per share and has a dividend yield of 0.7%. Jamieson Wellness pays an annual dividend of C$0.84 per share and has a dividend yield of 2.4%. Tecsys pays out 320.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Jamieson Wellness pays out 97.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Jamieson Wellness is clearly the better dividend stock, given its higher yield and lower payout ratio.
Tecsys has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, Jamieson Wellness has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.
Jamieson Wellness has a net margin of 5.43% compared to Tecsys' net margin of 0.86%. Jamieson Wellness' return on equity of 7.48% beat Tecsys' return on equity.
Summary
Jamieson Wellness beats Tecsys on 12 of the 19 factors compared between the two stocks.
Get Tecsys News Delivered to You Automatically
Sign up to receive the latest news and ratings for TCS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (TSE:TCS) was last updated on 1/24/2025 by MarketBeat.com Staff